Clozapine for self-injurious behavior in individuals with borderline personality disorder

Therapeutic Advances in Psychopharmacology

Volumn 3, Issue 5, 2013, Pages 272-274

  Zarzar, Theodore ^a   McEvoy, Joseph ^a  

^a Central Regional Hospital   (United States)

Author keywords

aggression; Borderline personality disorder; clozapine; suicide

Indexed keywords

CLOZAPINE;

ADULT; AGGRESSION; AGITATION; ANXIETY; AUTOMUTILATION; BORDERLINE STATE; CASE REPORT; CLINICAL OBSERVATION; DRUG BLOOD LEVEL; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MOOD; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; TREATMENT OUTCOME;

EID: 84998153458     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125313484323     Document Type: Article

References (14)

1. Benedetti F. Sforzini L. Colombo C. (1998) Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatr 59: 103–107.
2. Chengappa K. Ebeling T. Kang J. (1999) Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatr 60: 477–484.
3. Ferreri M. Loze J. Rouillon F. Limosin F. (2004) Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours. Eur Psychiatr 19: 177–178.
4. Frankenburg F. Zanarini M. (1993) Clozapine treatment of borderline patients: a preliminary study. Compr Psychiat 34: 402–405.
5. Gunderson J. (2008) Borderline Personality Disorder: A Clinical Guide. Washington, DC: American Psychiatric Publishing.
6. Krakowski M. Czobor P. Citrome L. Bark N. Cooper T. (2006) Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatr 63: 622–629.
7. Meltzer H. Alphs L. Green A. Altamura A. Anand R. Bertoldi A. et al. (2003) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatr 60: 82–91.
8. NICE (2009) Borderline personality disorder: treatment and management. Report CG78. London: National Institute for Health and Clinical Excellence. Available at: http://www.nice.org.uk/CG78 (accessed 12 March 2013).
9. Oldham J. Gabbard G. Goin M. Gunderson J. Soloff P. Spiege D. et al. (2001) Practice guideline for the treatment of patients with borderline personality disorder. Arlington, VA: American Psychiatric Association. Available at: http://psychiatryonline.org/content.aspx?bookid=28§ionid=1672600#54858 (accessed 12 March 2013).
10. Paris J. Zweig-Frank H. (2001) A 27-year follow-up of patients with borderline personality disorder. Compr Psychiat 42: 482–487.
11. Parker G. (2002) Clozapine and borderline personality disorder. Psychiat Serv 53: 348–349.
12. Stoffers J. Völlm B. Rücker G. (2010) Pharmacological interventions for borderline personality disorder. Cochrane Db Sys Rev 6: CD005653. DOI: 10.1002/14651858.CD005653.pub2.
13. Swinton M. (2001) Clozapine in severe borderline personality disorder. J Forensic Psychiatr 12: 580–591.
14. Vohra A. (2010) Treatment of severe borderline personality disorder with clozapine. Indian J Psychiatr 52: 267–269.